Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Is LAAO More Effective Stroke Prevention Than OAC in Patients With AFib and ESRD?Left atrial appendage occlusion (LAAO) was associated with a lower rate of a composite of ischemic stroke, systemic embolism (SE), major bleeding or all-cause mortality when compared with oral anticoagulation (OAC) with apixaban and warfarin for treating patients with end-stage renal disease (ESRD) who also have atrial fibrillation (AFib), according to a study published Oct. […]
- ACCEL Lite: PhysioSync-HF: Conduction System vs. Biventricular Pacing in Cardiac Resynchronization in HFrEFIn this interview, Drs. Joseph Marine and André Zimerman discuss “PhysioSync-HF: Conduction System vs. Biventricular Pacing in Cardiac Resynchronization in HFrEFâ€.
- Complications After Noncardiac Surgery Not Improved With Personalized Perioperative BP ManagementNeither individualized perioperative blood pressure (BP) management nor management stratified by risk of intraoperative hypotension improved outcomes in patients after noncardiac surgery, according to results of the IMPROVE-multi and PRETREAT trials, published recently in JAMA.
- JACC: Asia and JACC: Advances Now Eligible For Impact FactorsThe ACC is excited to announce that two of its JACC Journals – JACC: Asia and JACC: Advances – will receive an official Impact Factor, with the first rankings being issued in June 2026 as part of the Clarivate release.
- "Can We Clip It?": A Review of TEER in the Adult Congenital Heart Disease PopulationAtrioventricular valvular regurgitation (AVVR) is commonly seen in adults with congenital heart disease (ACHD), including those with congenitally corrected transposition of the great arteries (ccTGA), atrial switch correction for dextro-transposition of the great arteries (d-TGA), atrioventricular (AV) canal defect, and single-ventricle Fontan circulation.